2025
Impact of COVID‐19 Vaccination and Infection on Anti‐Triple‐Knockout (TKO) Pig Antibody Production: A Study in Patients With End‐Stage Liver Disease and Liver Transplant Recipients
Wang L, Zhuang L, Li T, Hara H, Cooper D, Leng J, Pan D, Zheng S, Wang Y, Xu X, Wei Q. Impact of COVID‐19 Vaccination and Infection on Anti‐Triple‐Knockout (TKO) Pig Antibody Production: A Study in Patients With End‐Stage Liver Disease and Liver Transplant Recipients. Xenotransplantation 2025, 32: e70050. PMID: 40375623, DOI: 10.1111/xen.70050.Peer-Reviewed Original ResearchConceptsEnd-stage liver diseaseEnd-stage liver disease patientsLT recipientsLiver transplantationCOVID-19 vaccineAntibody productionLiver diseaseAntibody levelsImpact of COVID-19 vaccinationTKO pig cellsLiver transplant recipientsAnti-pig antibody levelsActive COVID-19 infectionSARS-CoV-2 IgGTransplant recipientsCOVID-19 infectionEffectiveness of COVID-19 vaccinesHealthy controlsIgG levelsXenotransplant recipientsPig cellsHealthy individualsIgG antibodiesPatientsEnd-stage
2024
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk
O'Carroll A, Richard S, Byrne C, Rusiecki J, Wier B, Berjohn C, Fries A, Lalani T, Smith A, Mody R, Ganesan A, Huprikar N, Colombo R, Schofield C, Lindholm D, Mende K, Jones M, Flanagan R, Larson D, Ewers E, Saunders D, Maves R, Maldonado C, Sanchez Edwards M, O'Connell R, Simons M, Tribble D, Agan B, Burgess T, Pollett S. Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk. Open Forum Infectious Diseases 2024, 11: ofae557. PMID: 39494453, PMCID: PMC11530954, DOI: 10.1093/ofid/ofae557.Peer-Reviewed Original ResearchCase-control studySARS-CoV-2 infectionMilitary Health SystemVenous thrombosisMilitary Health System beneficiariesVTE risk factorsSARS-CoV-2COVID-19 vaccineMultivariate logistic regressionDays of SARS-CoV-2 infectionPost-coronavirus diseaseTime of infectionVTE diagnosisPositive SARS-CoV-2 testVTE riskRisk reductionSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Incident VTEEffectiveness of COVID-19 vaccinesSARS-CoV-2 testingVaccine seriesEmbolic riskRespiratory syndrome coronavirus 2
2023
Reply to Kleebayoon and Wiwanitkit on ‘Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis’
Rahmati M, Yon D, Lee S, Butler L, Koyanagi A, Jacob L, Shin J, Smith L. Reply to Kleebayoon and Wiwanitkit on ‘Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis’. Reviews In Medical Virology 2023, 34: e2490. PMID: 37975713, DOI: 10.1002/rmv.2490.Peer-Reviewed Original ResearchEffects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis
Rahmati M, Yon D, Lee S, Butler L, Koyanagi A, Jacob L, Shin J, Smith L. Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis. Reviews In Medical Virology 2023, 33: e2434. PMID: 36896895, DOI: 10.1002/rmv.2434.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionNeonatal ICU admissionNeonatal outcomesIntensive care unitMonths of lifeAssociated with vaccinationGestational agePreterm birthLow birthweightCOVID-19 vaccineNeonatal SARS-CoV-2 infectionEffectiveness of COVID-19 vaccinesMaternal SARS-CoV-2 infectionICU admissionSARS-CoV-2Higher risk of adverse outcomesOdds of preterm birthUnassisted vaginal deliveryRisk of adverse outcomesVery low birthweightMeta-analysisRisk of stillbirthConfidence intervalsSystematic reviewCalculate pooled effect sizes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply